Diabetic Foot

·MeSH: Diabetic Foot

13 drugs in development·11 companies·4 clinical trials

Drug Pipeline by Phase

Approved(5)

Drug	Company
altrazeal	ULURU INC. (ULU)
EPIFIX	MiMedx Group Inc (MDXG)
grafix	OSIRIS THERAPEUTICS, INC. (OSIR)
ultramist	SANUWAVE Health Inc. (SNWV)
xcellderma otc	REGENEREX PHARMA, INC. (RGPX)

Phase 3(1)

Drug	Company
skinte	POLARITYTE, INC. (COOL)

Phase 2(4)

Drug	Company
bx211	BiomX Inc. (PHGE)
cenplacel-l	Celularity Inc. (CELU)
PDA-002	Celularity Inc. (CELU)
tg-873870	Curative Biotechnology Inc (CUBT)

Preclinical(3)

BioSniper tracks 13 drugs in development for Diabetic Foot across 11 companies.

There are 4 clinical trials targeting Diabetic Foot tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.